Picture of Raily Aesthetic Medicine International Holdings logo

2135 Raily Aesthetic Medicine International Holdings Income Statement

0.000.00%
hk flag iconLast trade - 00:00
HealthcareHighly SpeculativeMicro CapValue Trap

Annual income statement for Raily Aesthetic Medicine International Holdings, fiscal year end - December 31st, CNY millions except per share, conversion factor applied.

2020
December 31st
2021
December 31st
2022
December 31st
2023
December 31st
2024
December 31st
Period Length:12 M12 M12 M12 M12 M
Source:ARSARSARSARSPRESS
Standards:
IFRS
IFRS
IFRS
IFRS
Status:FinalFinalFinalFinalFinal
Revenue
Total Revenue165188165189199
Cost of Revenue
Gross Profit80.269.766.871.571.4
Selling / General / Administrative Expenses
Research And Development
Unusual Expense / Income
Other Operating Expenses
Total Operating Expenses149205184220262
Operating Profit15.2-16.9-19.1-30.5-62.4
Total Net Non Operating Interest Income / Expense
Other Net Non Operating Costs
Net Income Before Taxes11.6-22.9-22.1-35-65.3
Provision for Income Taxes
Net Income After Taxes4.91-18.3-20.2-37.8-63.3
Minority Interest
Net Income Before Extraordinary Items
Net Income4.25-17.7-15.9-32.5-59.2
Income Available to Common Shareholders Excluding Extraordinary Items
Income Available to Common Shareholders Including Extraordinary Items
Diluted Net Income4.25-17.7-15.9-32.5-59.2
Diluted Weighted Average Shares
Basic EPS Including Extraordinary Items
Diluted EPS Including Extraordinary Items
Diluted EPS Excluding Extraordinary Items
Normalised Income Before Taxes
Normalised Income After Taxes
Normalised Income Available to Common Shareholders
Diluted Normalised EPS0.03-0.036-0.024-0.258-0.037